Targeting the Insulin-like Growth Factor 1 (IGF1R) and Insulin (IR) Receptor with a Dual IGF1R/IR Inhibitor, OSI-906, to Potentiate mTOR Inhibitor Effects in Exeperimental Models of Hepatocellular Carcinoma (HOC)

被引：0
|
作者：
Pivonello, Claudia [1 ]
Negri, Mariarosaria [1 ]
De Martino, Maria Cristina [1 ]
Napolitano, Maria [2 ]
de Angelis, Cristina [1 ]
Izzo, Francesco [2 ]
Colao, Annamaria [1 ]
Hofland, Leo J. [3 ]
Pivonello, Rosario [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Natl Canc Inst G Pascale Fdn, Naples, Italy
[3] Erasmus MC, Rotterdam, Netherlands
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT-0320
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs)
    Pantaleo, Maria A.
    Astolfi, Annalisa
    Nannini, Margherita
    Biasco, Guido
    JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [32] Insulin-like Growth Factor 1 Receptor (IGF1R) - A novel therapeutic target in chronic lymphocytic leukemia
    Yaktapour, N.
    Uebelhart, R.
    Schueler, J.
    Dierks, C.
    Burger, M.
    Pfeifer, D.
    Jumaa, H.
    Veelken, H.
    Brummer, T.
    Zirlik, K.
    ONKOLOGIE, 2013, 36 : 192 - 192
  • [33] Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia
    Yaktapour, Niuscha
    Uebelhart, Rudolf
    Schueler, Julia
    Aumann, Konrad
    Dierks, Christine
    Burger, Meike
    Pfeifer, Dietmar
    Jumaa, Hassan
    Veelken, Hendrik
    Brummer, Tilman
    Zirlik, Katja
    BLOOD, 2013, 122 (09) : 1621 - 1633
  • [34] A phase I study evaluating the combination of OSI-906, a dual inhibitor of insulin growth factor-1 receptor (IGF-1R) and insulin receptor (IR) with weekly paclitaxel (PAC) in patients with advanced solid tumors.
    Harb, W. A.
    Sessa, C.
    Hirte, H. W.
    Kaye, S. B.
    Simantov, R.
    Banerjee, S. N.
    Christinat, A.
    Sternberg, D. W.
    Singh, M.
    Light, R.
    Poondru, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs)
    Maria A Pantaleo
    Annalisa Astolfi
    Margherita Nannini
    Guido Biasco
    Journal of Translational Medicine, 8
  • [36] Mutations in insulin-like growth factor receptor 1 gene (IGF1R) resulting in intrauterine and postnatal growth retardation
    Leal, Andrea de Castro
    Machado Canton, Ana Pinheiro
    Montenegro, Luciana Ribeiro
    Coutinho, Debora Cabral
    Prado Arnhold, Ivo Jorge
    de Lima Jorge, Alexander Augusto
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2011, 55 (08) : 541 - 549
  • [37] Anti-tumor activities of a dual kinase inhibitor of the insulin-like growth factor receptor (IGF1R) and the epidermal growth factor receptor (EGFR/ERbB) families
    Wang, Jieyi
    Meulbroek, Jon
    Zhang, Qian
    Tucker, Lora
    Wilsbacher, Julie
    Hu, Xiaoming
    Pappano, William
    Hubbard, Robert
    Osterling, Donald
    Bouska, Jennifer
    Johnson, Eric
    Donawho, Cherrie
    Buchanan, Greg
    Sheppard, George
    Davidsen, Steve
    Bell, Randy
    CANCER RESEARCH, 2009, 69
  • [38] Phase I dose-escalation study of continuous oral dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), in patients with advanced solid tumors.
    Evana, T.
    Lindsay, C. R.
    Chan, E.
    Tait, B.
    Michael, S. A.
    Day, S.
    Stephens, A. W.
    Franke, A.
    Poondru, S.
    Puzanov, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] miR-223 regulates proliferation and apoptosis by targeting insulin-like growth factor 1 receptor (IGF1R) in osteosarcoma cells
    Xiao, Jianhua
    He, Chunlei
    Zhong, Yanchun
    Liu, Lulin
    Xiao, Yaosheng
    Liu, Wuyang
    MATERIALS EXPRESS, 2019, 9 (05) : 459 - 466
  • [40] miRNA-223 regulates ischemic neuronal injury by targeting the type 1 insulin-like growth factor receptor (IGF1R)
    Feng, She-Jun
    Zhang, Xue-Qiang
    Li, Jun-Tao
    Dai, Xiao-Min
    Zhao, Fei
    FOLIA NEUROPATHOLOGICA, 2018, 56 (01) : 49 - 57
12345